ATE412673T1 - Chimäres gapc protein aus streptococcus und dessen verwendung zur impfung und diagnostik - Google Patents

Chimäres gapc protein aus streptococcus und dessen verwendung zur impfung und diagnostik

Info

Publication number
ATE412673T1
ATE412673T1 AT01944803T AT01944803T ATE412673T1 AT E412673 T1 ATE412673 T1 AT E412673T1 AT 01944803 T AT01944803 T AT 01944803T AT 01944803 T AT01944803 T AT 01944803T AT E412673 T1 ATE412673 T1 AT E412673T1
Authority
AT
Austria
Prior art keywords
vaccination
streptococcus
diagnostics
gapc protein
chimeric gapc
Prior art date
Application number
AT01944803T
Other languages
English (en)
Inventor
Andrew Potter
Jose Perez-Casal
Michael Fontaine
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Application granted granted Critical
Publication of ATE412673T1 publication Critical patent/ATE412673T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01944803T 2000-06-12 2001-06-11 Chimäres gapc protein aus streptococcus und dessen verwendung zur impfung und diagnostik ATE412673T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21124700P 2000-06-12 2000-06-12

Publications (1)

Publication Number Publication Date
ATE412673T1 true ATE412673T1 (de) 2008-11-15

Family

ID=22786123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01944803T ATE412673T1 (de) 2000-06-12 2001-06-11 Chimäres gapc protein aus streptococcus und dessen verwendung zur impfung und diagnostik

Country Status (12)

Country Link
US (4) US6660270B2 (de)
EP (1) EP1294771B1 (de)
AR (1) AR028713A1 (de)
AT (1) ATE412673T1 (de)
CA (1) CA2411919C (de)
CY (1) CY1108724T1 (de)
DE (1) DE60136356D1 (de)
DK (1) DK1294771T3 (de)
ES (1) ES2316450T3 (de)
PT (1) PT1294771E (de)
UY (1) UY26763A1 (de)
WO (1) WO2001096379A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833134B2 (en) * 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
BR0313237A (pt) 2002-08-12 2005-07-12 Akzo Nobel Nv Sequência de ácido nucleico, fragmento de dna, molécula de dna recombinante, veìculo recombinante vivo, célula hospedeira, proteìna de streptococcus uberis, usos da mesma e de uma sequência de ácido nucleico, de um fragmento de dna, de uma molécula de dna recombinante, de um veìculo recombinante vivo, de uma célula hospedeira ou de uma proteìna ou de um fragmento imunogênico da mesma, vacina, método para a preparação da mesma, e, kit diagnóstico
US20060118009A1 (en) * 2004-12-07 2006-06-08 Hubbs Jonathan W Soil conditioner
US20070048096A1 (en) * 2004-12-07 2007-03-01 Hubbs Jonathan W Soil conditioner
US9216212B2 (en) * 2005-08-05 2015-12-22 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
US7951384B2 (en) * 2005-08-05 2011-05-31 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
US8012730B1 (en) * 2006-08-29 2011-09-06 The United States Of America As Represented By The Secretary Of Agriculture Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin
EP2023143A1 (de) * 2007-08-06 2009-02-11 Boehringer Ingelheim Vetmedica Gmbh Immunogene Streptokokkus-Proteine
US20100088957A1 (en) * 2008-10-09 2010-04-15 Hubbs Jonathan W Natural turf with binder
US20100216639A1 (en) * 2009-02-20 2010-08-26 Hubbs Jonathon W Gypsum soil conditioner
US8147849B2 (en) * 2009-02-20 2012-04-03 Novartis Ag Protective antigens for group B Streptococcus hypervirulent strains

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE459503B (sv) 1985-05-03 1989-07-10 Excorim Kommanditbolag Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g
US4954618A (en) 1986-02-14 1990-09-04 Genex Corporation Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G
US5198215A (en) * 1987-06-22 1993-03-30 Noordzee Laboratorium N.V. Composition for controlling mastitis in ruminants, method for its preparation and method of treatment of ruminants
US4977082A (en) 1987-12-10 1990-12-11 University Of Florida Research Foundation, Inc. Type VI bacterial FC receptors
US5472696A (en) 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5237050A (en) 1989-03-29 1993-08-17 University Of Florida Research Foundation, Inc. Bacterial plasmin receptors as fibrinolytic agents
US5328996A (en) 1989-03-29 1994-07-12 University Of Florida Research Foundation, Inc. Bacterial plasmin receptors as fibrinolytic agents
US5476929A (en) 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein
AU668908B2 (en) * 1992-01-08 1996-05-23 Rockefeller University, The Multifunctional surface protein of streptococci
ATE214601T1 (de) * 1992-09-16 2002-04-15 Univ Tennessee Res Corp Rekombinantes vielwertiges m-protein-vakzin
CN1192241A (zh) 1995-06-07 1998-09-02 生化疫苗公司 Hsp70家族的链球菌热休克蛋白
US5863543A (en) 1996-06-05 1999-01-26 University Of Saskatchewan Camp factor of streptococcus uberis
WO1996041879A1 (en) 1995-06-08 1996-12-27 University Of Saskatchewan Camp factor of streptococcus uberis
JP3357071B2 (ja) * 1996-03-29 2002-12-16 日本ゼオン株式会社 新規な融合タンパク質、その遺伝子、組み換えベクター、及び組み換えウイルスとその利用
DE69737125T3 (de) * 1996-10-31 2015-02-26 Human Genome Sciences, Inc. Streptococcus pneumoniae-Antigene und Impfstoffe
US6485904B1 (en) * 1997-06-23 2002-11-26 Pfizer, Inc. DNA encoding a plasminogen activating protein
EP1757697A3 (de) 1998-02-20 2007-05-30 ID Biomedical Corporation Gruppe B-Streptococcus Antigene
TR200200633T2 (tr) 1998-12-23 2002-06-21 Shire Biochem Inc. Yeni streptococcus antijenleri
US6391316B1 (en) * 1999-03-10 2002-05-21 University Of Saskatchewan Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use

Also Published As

Publication number Publication date
DE60136356D1 (de) 2008-12-11
CY1108724T1 (el) 2014-04-09
CA2411919A1 (en) 2001-12-20
ES2316450T3 (es) 2009-04-16
US6660270B2 (en) 2003-12-09
US7258992B2 (en) 2007-08-21
US20020044928A1 (en) 2002-04-18
US20080009022A1 (en) 2008-01-10
US20050142615A1 (en) 2005-06-30
US6875853B2 (en) 2005-04-05
PT1294771E (pt) 2009-01-06
EP1294771A2 (de) 2003-03-26
WO2001096379A3 (en) 2002-08-08
EP1294771B1 (de) 2008-10-29
CA2411919C (en) 2012-07-31
AR028713A1 (es) 2003-05-21
WO2001096379A2 (en) 2001-12-20
UY26763A1 (es) 2001-08-27
DK1294771T3 (da) 2008-12-15
US20040062774A1 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
CY2019029I2 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
IL228034A0 (en) Formulations with a high concentration of antibodies and proteins
DE50105494D1 (de) Filterelement zur stirnseitigen anströmung
DE60136324D1 (de) Vorrichtung zum auswerten biologischer informationen
DE60207183D1 (de) Vorrichtung zur Beobachtung biologischer Daten
DE60128306D1 (de) Zwischenmedium für Übertragungsaufzeichnungsverfahren und Bebilderungsverfahren
AU4141101A (en) Nucleic acids, proteins, and antibodies
IL169804A (en) 254p1d6b proteins, nucleic acids encoding the same, processes for producing the same, antibodies binding thereto and uses thereof
NO20024844D0 (no) Fremgangsmåte for fremstilling av börstehår for påföring av medier, börstehår fremstilt med fremgangsmåte og börstevare medslike börstehår
EP1575992A4 (de) Chimäre proteine aus proteintransduzierender domäne/deaminase, verwandte verbindungen und deren verwendungen
ATE412673T1 (de) Chimäres gapc protein aus streptococcus und dessen verwendung zur impfung und diagnostik
EP1229330A4 (de) Sonde zum analysieren von protein-protein-wechselwirkungen und entsprechendes verfahren dafür
DE50206164D1 (de) Substituierte indole verfahren zu deren herstellung und deren verwendung zur schmerzbekämfung
EP1267930A4 (de) Kreuzreaktive, verdrängende antikörper von kollagenbindeproteinen, identifizierungsverfahren und verwendung
AU2001296301A8 (en) Nucleic acids, proteins, and antibodies
EP1621616A4 (de) Menschlicher anti-mensch-interleukin-18-antikörper, fragment davon und verfahren zu deren verwendung
DE60141790D1 (de) Chromatographische probe und verfahren zu ihrer herstellung
DE50111106D1 (de) Keramisches filterelement und verfahren zu seiner herstellung
EP1634960A4 (de) Sonden zur analyse der wechselwirkung zwischen proteinen und verfahren zur analyse der wechselwirkung zwischen proteinen damit
DE60112487D1 (de) Verfahren und Gerät zur Steuerung , und Aufnahmemedium
ATE423573T1 (de) Azithromycin enthaltende stabilisierte suspensionen zur oralen anwendung
AU3095801A (en) Nucleic acids, proteins, and antibodies
ZA200208700B (en) Method and probes for the genetic diagnosis of hemo-chromatosis.
AU2001236466A8 (en) Nucleic acids, proteins, and antibodies
SI1610820T1 (sl) Visokokoncentrirane formulacije protitelesa in proteinov

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1294771

Country of ref document: EP